[PDF][PDF] Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club
The EuroCTO club was established in December 2006. In 2007 it published its first
consensus document on the recanalisation of Chronic Total Occlusions (CTOs), aiming to …
consensus document on the recanalisation of Chronic Total Occlusions (CTOs), aiming to …
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
C Pristipino, H Sievert, F D'ascenzo… - European Heart …, 2019 - academic.oup.com
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …
of medical conditions; however, the subject remains controversial and no official statements …
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review
EB Wu, ES Brilakis, K Mashayekhi… - Journal of the American …, 2021 - jacc.org
The authors developed a global chronic total occlusion crossing algorithm following 10
steps: 1) dual angiography; 2) careful angiographic review focusing on proximal cap …
steps: 1) dual angiography; 2) careful angiographic review focusing on proximal cap …
[HTML][HTML] Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke
L Søndergaard, SE Kasner, JF Rhodes… - … England Journal of …, 2017 - Mass Medical Soc
Background The efficacy of closure of a patent foramen ovale (PFO) in the prevention of
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic …
NE Moat, P Ludman, MA De Belder… - Journal of the American …, 2011 - jacc.org
Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …
[HTML][HTML] Percutaneous closure of patent foramen ovale in cryptogenic embolism
Background The options for secondary prevention of cryptogenic embolism in patients with
patent foramen ovale are administration of antithrombotic medications or percutaneous …
patent foramen ovale are administration of antithrombotic medications or percutaneous …
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin …
Background We hypothesised that ticagrelor, in combination with aspirin for 1 month,
followed by ticagrelor alone, improves outcomes after percutaneous coronary intervention …
followed by ticagrelor alone, improves outcomes after percutaneous coronary intervention …
[HTML][HTML] Dual antiplatelet therapy after PCI in patients at high bleeding risk
Background The appropriate duration of dual antiplatelet therapy in patients at high risk for
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
bleeding after the implantation of a drug-eluting coronary stent remains unclear. Methods …
Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry
Background—Transcatheter aortic valve-in-valve implantation is an emerging therapeutic
alternative for patients with a failed surgical bioprosthesis and may obviate the need for …
alternative for patients with a failed surgical bioprosthesis and may obviate the need for …
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves
Importance Owing to a considerable shift toward bioprosthesis implantation rather than
mechanical valves, it is expected that patients will increasingly present with degenerated …
mechanical valves, it is expected that patients will increasingly present with degenerated …